Atlas Trials

Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

Clinical trial NCT05811442 · COMPLETED

Trial details

NCT number
NCT05811442
Sponsor
Beijing Joekai Biotechnology LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2023-04-18
Primary completion
2025-08-22
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.